Pharma Mar SA
Arancha Garces Hecht has extensive work experience in the pharmaceutical industry. ARANCHA began their career in 2001 as a Technical Director at Suanfarma, S.A, and remained in this role until 2002. ARANCHA then moved to TORREFARMA, S.L. as a Technical Director from 2002 to 2005. Following this, they joined Suanfarma, S.A. as an Area Manager from 2005 to 2008. ARANCHA then transitioned to Suanfarma Biotech as a Project Manager from 2008 to 2010. Since 2010, they have been working at PharmaMar, starting as a Business Development & Licensing Manager until 2015. Currently, they hold the position of Associate Director, with a focus on Business Development, Licensing, and Alliance Management.
Arancha Garces Hecht obtained a degree in Pharmacy from Universidad CEU San Pablo, spanning from 1995 to 2001. No further education history is provided beyond this.
This person is not in any offices
Pharma Mar SA
Pharma Mar SA is a Spain-based company engaged in the bio therapeutic drugs manufacture. The Company focuses on research, development and marketing of bio-active principles, primarily from marine origin, for application in human diseases treatment, including antitumour, antiviral and immunomodulation, as well as tropical diseases areas. It manufactures and sells Yondelis, a synthetically modified antitumor agent, which is derived from sea squirts and is implemented in the treatment of soft tissue sarcomas and relapsed ovarian cancer. Furthermore, the Company's products pipeline comprises drug candidates and agents for cancer treatment, such as Aplidin, PM01183 and PM060184. The Company operates through subsidiaries in Italy, Germany, France, and the United States, among others.